Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jing wang Bi"'
Autor:
Li Yin, Xing-yu Li, Lin-lin Zhu, Gui-lai Chen, Zhuo Xiang, Qing-qing Wang, Jing-wang Bi, Qiang Wang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Image-guided tumor ablation eliminates tumor cells by physical or chemical stimulation, which shows less invasive and more precise in local tumor treatment. Tumor ablation provides a treatment option for medically inoperable patients. Currently, clin
Externí odkaz:
https://doaj.org/article/111576f282ae4e2aa19e3f133d915e2e
Autor:
Rui-Hua Xu, Lin Shen, Ke-Ming Wang, Gang Wu, Chun-Mei Shi, Ke-Feng Ding, Li-Zhu Lin, Jin-Wan Wang, Jian-Ping Xiong, Chang-Ping Wu, Jin Li, Yun-Peng Liu, Dong Wang, Yi Ba, Jue-Ping Feng, Yu-Xian Bai, Jing-Wang Bi, Li-Wen Ma, Jian Lei, Qing Yang, Hao Yu
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-9 (2017)
Abstract Background Metastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies need new medication for further treatment. Famitinib is a small-molecule multikinase inhibitor, with promising anticancer
Externí odkaz:
https://doaj.org/article/60f8fa644b284514af46dc26b0515928
Publikováno v:
Biomedicine & Pharmacotherapy. 162:114648
Publikováno v:
Huan jing ke xue= Huanjing kexue. 41(4)
In this study, watermelon rind was used as a raw material to modify watermelon rind biochar (MBC) with ammonium sulphate[(NH
Publikováno v:
Fundamentalclinical pharmacologyReferences. 34(6)
This study aimed to investigate the role of ANXA13 in lung adenocarcinoma (LUAD) growth, migration, and the underlying mechanisms. Firstly, in the TCGA dataset for LUAD, ANXA13 is found to be highly expressed in patients with LUAD and high expression
Autor:
Hao Yu, Yi Ba, Gang Wu, Li-Wen Ma, Jin Li, Rui-Hua Xu, Jian Lei, Ke-Feng Ding, Chunmei Shi, Jinwan Wang, Yuxian Bai, Lizhu Lin, Jianping Xiong, Dong Wang, Ke-Ming Wang, Jueping Feng, Jing-Wang Bi, Lin Shen, Yunpeng Liu, Qing Yang, Changping Wu
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-9 (2017)
Chinese Journal of Cancer
Chinese Journal of Cancer
Background Metastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies need new medication for further treatment. Famitinib is a small-molecule multikinase inhibitor, with promising anticancer activiti
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Background: Whether body mass index (BMI) is associated with the risk of mortality from lung cancer (LC) is controversial, and the shape of dose–response relationship on this topic is not w
Background: Whether body mass index (BMI) is associated with the risk of mortality from lung cancer (LC) is controversial, and the shape of dose–response relationship on this topic is not w
Autor:
Ya hong Sun, Jun ye Wang, Chun tang Wang, Jing wang Bi, Zhig Wei, Xing lu Xu, Li cheng Zhang, Qing liang Feng, Kai xian Zhang, Dian zhong Geng, Yu ting Dong, Xin Ye, Deng jun Sun, Hai peng Ren, Ben hua Zhang
Publikováno v:
Journal of Clinical Oncology. 35:9048-9048
9048 Background: Previous studies showed that advanced non small cell lung cancer (NSCLC) benefited from microwave ablation in combination with platium-based doublet chemotherapy. This prospective, randomized, phase III clinical trial aimed to determ
Autor:
Jing-Wang Bi, Changping Wu, Yi Ba, Gang Wu, Jin Li, Jian Lei, Hao Yu, Chunmei Shi, Yunpeng Liu, Lizhu Lin, Dong Wang, Jianping Xiong, Jinwan Wang, Kefeng Ding, Ke-Ming Wang, Yuxian Bai, Rui-Hua Xu, Jueping Feng, Lin Shen, Liwen Ma
Publikováno v:
Journal of Clinical Oncology. 33:513-513
513 Background: Colorectal cancer (CRC) is the third most frequently diagnosed cancer and is the fifth leading cause of cancer death in China. No standard care is available for patients with advanced CRC who failed the second-line treatment. Famitini
Autor:
Ning Shen, Ping Fu, Bin Cui, Chun-Ying Bu, Jing-Wang Bi, Shen, Ning, Fu, Ping, Cui, Bin, Bu, Chun-Ying, Bi, Jing-Wang
Publikováno v:
Medicine; 8/25/2017, Vol. 96 Issue 34, p1-7, 7p